In vivo dendritic cell reprogramming for cancer immunotherapy

Immunotherapy can lead to long-term survival for some cancer patients, yet generalized success has been hampered by insufficient antigen presentation and exclusion of immunogenic cells from the tumor microenvironment. Here, we developed an approach to reprogram tumor cells in vivo by adenoviral deli...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Science
Autores principales: Ascic, Ervin, Åkerström, Fritiof, Nair, Malavika Sreekumar, Rosa, André, Kurochkin, Ilia, Zimmermannova, Olga, Catena, Xavier, Rotankova, Nadezhda, Veser, Charlotte, Rudnik, Michal, Ballocci, Tommaso, Schärer, Tiffany, Huang, Xiaoli, de Rosa Torres, Maria, Renaud, Emilie, Santiago, Marta Velasco, Met, Özcan, Askmyr, David, Lindstedt, Malin, Greiff, Lennart, Ligeon, Laure-Anne, Agarkova, Irina, Svane, Inge Marie, Pires, Cristiana F., Rosa, Fábio F., Pereira, Carlos-Filipe
Formato: Artigo
Lenguaje:Inglês
Publicado: 2024
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616765/
https://ncbi.nlm.nih.gov/pubmed/39236156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.adn9083
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares